caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1093787137

Lori Bigi

Internal MedicineSewickley, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (6)

CCN 398146
Home health agency
CCN 390036
Hospital
CCN 390037
Hospital
CCN 390107
Hospital
CCN 390114
Hospital
CCN 390164
Hospital
REFERRAL NETWORK

Where Lori Bigi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
UPMC PRESBYTERIAN SHADYSIDE82814
UPMC MAGEE-WOMENS HOSPITAL1755
Quest Diagnostics Venture Llc
Clinical Laboratory · Pittsburgh, PA
1644
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
449
Unique beneficiaries
—
Total services
510
Distinct HCPCS
10
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 4,434 Internal Medicine providers in PA — above median (cohort median 550).
PRESCRIBING · PART D · 2024
Total Rx claims
7,060
Beneficiaries
—
Total drug cost
$497K
Distinct drugs
117
Brand share
18.9%
Top prescribed drugs
Atorvastatin Calcium524 claims
Losartan Potassium422 claims
Levothyroxine Sodium362 claims
Amlodipine Besylate322 claims
Rosuvastatin Calcium280 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
83.8
Quality
70.5
Cost
75.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.37%
Group